top of page
Search
Writer's pictureKonstantinos Tsilkos

DermSpectra In The Press: Read Dr. Kline Exclusive Interview!


Following is an excerpt from the original interview published on Charlotte’s Book:

Diagnosing skin cancer has always been complicated: delays can cause major problems, but early detection can save lives. So where’s the technology we’ve all been waiting for that can “read” and diagnose skin, no matter the stage? Meet DermaSpectra, a major technological revolution in the way doctors can diagnose and monitor skin conditions, including moles, psoriasis, eczema, and lesions. It’s a full-body imaging system that reads and saves the information in your skin, comparing that information to the next time you visit the doctor’s office. Charlotte’s Book approved dermatologist Dr. Mitchell A. Kline is only one of two institutions in the U.S. to be receiving DermaSpectra: his office in New York will have a machine, and the Oregon Health & Science University will be receiving the only other DermaSpectra machine in the U.S. We spoke to Dr. Kline to get the full download on this high-tech imaging system. Read on, and avoid skin cancer. CB: WHAT IS DERMASPECTRA IN EASY-TO-UNDERSTAND TERMS? Dr. Mitchell A. Kline: DermSpectra is a cutting-edge total body digital imaging system that functions like a technically advanced photo booth for the skin. It allows a dermatologist to use modern, standardized methods to visually capture, track, detect and monitor vital skin irregularities that could indicate an underlying health issue or aid in the early detection of skin cancer.

Keep reading the full feature on Charlotte’s Book.

45 views0 comments

Recent Posts

See All

Masks Are Not Political

Despite the perception of a current politically aligned choice of mask wearing we will not be accepting anyone, employee or patient, who...

Better PDT Year-round

PDT (Photodynamic Therapy) #pdt #DUSA Why we think ours works better and what we think about summer treatment at Kline Dermatology. #...

Prescription Access and Costs

What‘s happening with drug pricing is highly complex. It is much more than the price setting by big pharma, much more than the price...

Comentários


bottom of page